Speranskoside
Speranskoside is a dual COX-2/15-LOX inhibitor with a COX-2 IC50 of 2.62 μg/mL and a 15-LOX IC50 of 5.51 μg/mL. Speranskoside can be used for the research of gastric ulcers.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 219917-70-1
- Formel: C30H28O12
- Molecular Weight:580.54
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
|
COX-2 2.62 μg/mL (IC50) |
15-LOX 5.51 μg/mL (IC50) |
Speranskoside (Compound E7) (0.25-500 μg/mL) potently inhibits the COX-2 enzyme, with an IC50 value of 2.62 μg/mL[1].
Speranskoside (0.25-500 μg/mL) potently inhibits the 15-LOX enzyme, with an IC50 value of 5.51 μg/mL[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 219917-70-1
-
Molecular Weight 580.54
-
Formel C30H28O12
-
SMILES
O=C1C2=C(O)C=C(O[C@@H]3O[C@@H]([C@H]([C@@H]([C@H]3O)O)OC(/C=C/C4=CC=C(C=C4)O)=O)CO)C=C2O[C@H](C5=CC=C(C=C5)O)C1
-
Structure Classification
-
Initial Source
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)